A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Altrenogest Impurity 1 - Request Quote

Picture of Altrenogest Impurity 1

Altrenogest Impurity 1

SZ CAT No:SZ-A180002
CAS No
NA
Mol.F.
C21H26O2
Mol.Wt.
310.4
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Altrenogest Impurity 1 is chemically (8S,13R,14S,17S)-17-allyl-13-methyl-1,6,7,8,11,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthrene-3,12(2H)-dione. Altrenogest Impurity 1 is supplied with detailed characterization data compliant with regulatory guideline. Altrenogest Impurity 1 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Altrenogest.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Altrenogest Impurity 1

Purchase Altrenogest Impurity 1

Altrenogest Impurity 1 suppliers

Altrenogest Impurity 1 manufacturers

Altrenogest Impurity 1 price

Order Altrenogest Impurity 1

Enquire Altrenogest Impurity 1

Altrenogest Impurity 1 cost

Altrenogest Impurity 1 Supplier

Altrenogest Impurity 1 Distributor

Altrenogest Impurity 1 for Method Validation

Altrenogest Reference Standard

Altrenogest Impurity 1 for ANDA Filing

Altrenogest Impurity 1 for Forced Degradation Studies

Altrenogest Impurity 1 Identification Standards

Altrenogest Impurity 1 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,